Schwank Simone Eliane, Chung Ho-Fung, Hsu Mandy, Fu Shih-Chien, Du Li, Zhu Liping, Huang Hsuan-Ying, Andersson Ewa, Acharya Ganesh
CLINTEC, Karolinska Institute, Stockholm, Sweden
Women's Health and Perinatology Research Group, Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
BMJ Open. 2020 Nov 27;10(11):e041133. doi: 10.1136/bmjopen-2020-041133.
Mental health disorders are common during pregnancy and the postnatal period and can have serious adverse effects on women and their children. The consequences for global mental health due to COVID-19 are likely to be significant and may have a long-term impact on the global burden of disease. Besides physical vulnerability, pregnant women are at increased risk of mental health problems such as anxiety, depression and post-traumatic stress disorder due to the consequences of social distancing. It can result in altered healthcare routines, less support from the family and friends, and in some cases, partners not being allowed to be present during prenatal visits, labour and delivery. Higher than expected, rates of perinatal anxiety and depression have been already reported during the pandemic. Pregnant women may also feel insecure and worried about the effects of COVID-19 on their unborn child if they get infected during pregnancy. Today, young urban women are used to using internet services frequently and efficiently. Therefore, providing mental health support to pregnant women via internet may be effective in ameliorating their anxiety/depression, reducing the risk of serious mental health disorders, and lead to improved maternal and perinatal outcomes.
Our aim is to explore the effectiveness of a web-based psychosocial peer-to-peer support intervention in reducing the risk and severity of perinatal mental health disorders and preventing adverse pregnancy outcomes among pregnant women living in metropolitan urban settings.
We plan to conduct a multicentre prospective randomised controlled trial, Mental health of Urban Mothers trial. Pregnant women living in large metropolitan cities will be recruited using internet-based application through non-profit organisations' websites. The women who consent will be randomised to receive a web-based peer-to-peer support intervention or usual care. Data will be analysed to identify the effects of intervention on Edinburgh Postnatal Depression Score and Generalised Anxiety Disorder 7 scores as well as pregnancy outcomes. The impact of COVID-19 pandemic on maternal stress will be assesed using Impact Event Scale-R. Any differences in outcomes between cities will be addressed in subgroup analyses.
The study will be conducted according to the principles of Good Clinical Practice and will follow the ethical principles of the Declaration of Helsinki. The study protocol has been approved by the ethical review board of Chinese University of Hong Kong (IRB number 2019-8170) and Shanghai Center for Women's and Children's Health (international review board (IRB) number 2020-F001-12). The results will be disseminated at national and international scientific conferences, published in peer-reviewed medical journals and spread to the public through social media, news outlets and podcasts.
NCT04363177; Trial sponsor Karolinska Institute, CLINTEC, Stockholm, Sweden.
心理健康障碍在孕期和产后很常见,会对女性及其子女产生严重的不良影响。2019年冠状病毒病(COVID-19)对全球心理健康的影响可能很大,可能会对全球疾病负担产生长期影响。除了身体上的脆弱性外,由于社交距离措施的影响,孕妇出现焦虑、抑郁和创伤后应激障碍等心理健康问题的风险增加。这可能导致医疗保健常规改变、家人和朋友的支持减少,在某些情况下,伴侣在产前检查、分娩时不被允许在场。在疫情期间,围产期焦虑和抑郁的发生率高于预期。如果孕妇在孕期感染COVID-19,她们可能还会感到不安全,并担心该疾病对未出生胎儿的影响。如今,年轻的城市女性习惯于频繁且高效地使用互联网服务。因此,通过互联网为孕妇提供心理健康支持可能有助于缓解她们的焦虑/抑郁情绪,降低严重心理健康障碍的风险,并改善孕产妇和围产期结局。
我们的目标是探索一种基于网络的心理社会同伴支持干预措施在降低生活在大城市的孕妇围产期心理健康障碍的风险和严重程度以及预防不良妊娠结局方面的有效性。
我们计划开展一项多中心前瞻性随机对照试验——城市母亲心理健康试验。将通过非营利组织的网站,利用基于互联网的应用程序招募居住在大城市的孕妇。同意参与的女性将被随机分组,分别接受基于网络的同伴支持干预或常规护理。将对数据进行分析,以确定干预措施对爱丁堡产后抑郁量表评分和广泛性焦虑障碍7项量表评分以及妊娠结局的影响。将使用影响事件量表-R评估COVID-19大流行对孕产妇压力的影响。城市之间结局的任何差异将在亚组分析中进行探讨。
本研究将按照《药物临床试验质量管理规范》的原则进行,并遵循《赫尔辛基宣言》的伦理原则。研究方案已获得香港中文大学伦理审查委员会(IRB编号2019 - 8170)和上海市妇女儿童健康中心(国际审查委员会(IRB)编号2020 - F001 - 12)的批准。研究结果将在国内和国际科学会议上公布,发表在同行评审的医学期刊上,并通过社交媒体、新闻媒体和播客向公众传播。
NCT04363177;试验主办方:瑞典斯德哥尔摩卡罗林斯卡学院、CLINTEC。